منابع مشابه
Immune Prognostic Factors in Ovarian Cancer: Lessons from Translational Research
Phyllis A. Gimottya, Lin Zhangb, Ioannis Alagkiozidisb, Mark Cadungogb, Sarah Adamsb, Christina Chub, Dionysios Katsarosc and George Coukosb,d Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104, USA Center for Research on Reproduction and Women’s Health, University of Pennsylvania, Philadelphia, PA 19104, USA Department of Obstetrics and Gynecology,...
متن کاملTranslational research in breast cancer.
Translational research (TR) involves both the development of novel diagnostics and novel therapeutics. These two major developmental areas are often associated with each other and these associations often bring new paradigms in the management of cancer patients. For example, the development of trastuzumab-based treatments has been conducted in harmony with the development of new methodologies t...
متن کاملTranslational research in breast cancer.
routine. This also explains the interest of a larger public in these issues; breast cancer activists are willing to take up a role in the creation of biological and clinical databases. Patients are asked to lobby for and help in clinical studies. On the other hand, the access to human tissues is only possible via the patient. The discussion around the Human Tissue Act in Britain may serve as on...
متن کاملTranslational Research in Pancreatic Cancer
169: KRAS mutations in a population of patients operated for pancreatic adenocarcinoma [5] Researchers from Denmark presented a translational study on KRAS mutations in early pancreatic cancer. Previous reports had showed that the frequency of KRAS gene mutations in pancreatic cancer was as high as 75-90% [2]. This high percentage of KRAS mutations was representative of all pancreatic cancer st...
متن کاملTranslational cancer research in Europe.
Currently health services in Europe face the seemingly insurmountable challenge of funding trastuzumab (Herceptin) within their limited budgets for women with early stage breast cancer. Martine Piccart-Gebhart (Institute Jules Bordet, Brussels, Belgium) believes we would not now be confronting this huge financial burden had a translational research component been introduced upfront to trastuzum...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancers
سال: 2020
ISSN: 2072-6694
DOI: 10.3390/cancers12123676